Related Experiment Video
Updated: Jul 6, 2025

10:38
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
9.0K
Distinct mesenchymal cell states mediate prostate cancer progression
Hubert Pakula1, Mohamed Omar1,2, Ryan Carelli1
1Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, 10021, USA.
Nature Communications
|January 8, 2024
Summary
Researchers explored mesenchymal cells in the tumor microenvironment (TME) to understand prostate cancer (PCa) progression. They identified stromal cell signatures predicting metastasis, offering new prognostic tools and therapeutic targets for PCa.
Area of Science:
- Oncology
- Cell Biology
- Genomics
Background:
- Mesenchymal cells are crucial in the tumor microenvironment (TME).
- Their specific roles in prostate cancer (PCa) progression and metastasis are not fully understood.
- Understanding stromal dynamics is key to deciphering PCa pathogenesis.
Purpose of the Study:
- To delineate molecular changes in tumor stroma influencing PCa progression and metastasis.
- To identify specific mesenchymal cell populations and their functions in PCa.
- To develop novel prognostic markers for PCa metastasis.
Main Methods:
- Single-cell RNA sequencing of mesenchymal cells from mouse models and human tumors.
- Comparative analysis of stromal cell transcriptional identities across species.
- Correlation of stromal signatures with PCa progression and bone metastasis.
Main Results:
- Identified eight distinct stromal cell populations with conserved transcriptional identities in mice and humans.
- Stromal signatures in advanced mouse PCa mirror human bone metastases.
- Highlighted periostin's role in PCa invasion and differentiation.
- Derived a gene signature predicting metastatic progression in localized PCa.
Conclusions:
- Stromal cell dynamics significantly influence prostate cancer progression and metastasis.
- Identified key mesenchymal cell populations and their roles in PCa.
- Developed a novel gene signature for predicting PCa metastatic risk, potentially improving patient stratification and treatment strategies.
Related Concept Videos
Mesenchymal Stem Cells
4.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

